Association of Glucagon-Like Peptide-1 Receptor Agonist Use With Risk of Gallbladder and Biliary Diseases: A Systematic Review and Meta-analysis
If you are new to GLP-1 medications or have not taken one recently, you will begin with the Foundation Plan
May 27, 2019.
These drugs also simultaneously decrease levels of an enzyme called DPP-4, which inactivates GLP-1
The goal is always to identify what is actually driving the symptoms and prescribe accordingly, which is why the conversation starts with a consultation and labs rather than a product selection
Andersson, Emmanuel Shapira, Biochemical and clinical response to hydroxocobalamin versus cyanocobalamin treatment in patients with methylmalonic acidemia and homocystinuria (cblC), The Journal of Pediatrics, Volume 132, Issue 1, January 1998, Pages 121-124, ISSN 0022-3476, Okuda K, Yashima K, Kitazaki T, Takara I